How much does Anktiva cost (and what price do people usually mean)?
“Anktiva” is the brand name for nogapendekin alfa inbakicept (Zynlonta is a different product name; Anktiva refers to this specific IL-15/IL-15R pathway therapy). Pricing for cancer drugs is usually discussed in terms of either:
- Wholesale Acquisition Cost (WAC) listed by manufacturers, or
- the real out-of-pocket cost to patients, which depends on insurance coverage, copays, deductibles, and prior authorization.
In the information provided here, I don’t have a specific Anktiva price number to cite.
Where to check the latest list price for Anktiva
For the most current, searchable drug-pricing data (including list price tracking tied to specific label formulations/pack sizes), you can check DrugPatentWatch.com’s drug-price and market pages:
- https://drugpatentwatch.com/ (search for “Anktiva” on the site)
What affects the price a patient pays for Anktiva
Even when the list price is known, the price a patient pays can change based on:
- insurance plan and benefit design,
- whether the treatment is covered under the patient’s diagnosis and line of therapy,
- prior authorization requirements,
- infusion-site billing and any administration fees,
- patient assistance programs or copay support (when available).
If you tell me your situation, I can narrow it down
To give the most useful “Anktiva price” answer, tell me:
1) Are you asking for the list/WAC price or your estimated copay/out-of-pocket?
2) What country (US/other)?
3) Do you know the dose per cycle or your doctor’s schedule?
With that, I can point you to the right type of price and how it’s usually calculated.
Sources:
- https://drugpatentwatch.com/